Explore the fascinating world of CD4⁻CD8⁻ alpha beta T cells - rare immune cells that challenge conventional immunology with their unique properties and functions.
Discover how scientists are optimizing Illudin M production from bioluminescent mushrooms for cancer therapy development through metabolic engineering and bioengineering techniques.
Exploring the paradoxical oncolytic viral activity of SARS-CoV-2 and its potential to revolutionize cancer treatment through immune reactivation and direct cancer cell targeting.
Discover how halotolerant Bacillus bacteria from extreme environments show promising cytotoxic effects against kidney cancer cells, opening new frontiers in oncology.
Explore how CRISPR base editing technology is revolutionizing treatment for Hutchinson-Gilford Progeria Syndrome, a rare premature aging disorder.
Discover how adalimumab is revolutionizing treatment for Cutaneous Crohn's Disease by targeting the gut-skin connection through advanced biologic therapy.
Comprehensive guide to optimizing treatment sequencing for NSCLC patients with actionable mutations, covering precision oncology, molecular targets, and clinical trial data.
Discover how Chlamydomonas reinhardtii is being developed as a sustainable biofactory for recombinant therapeutic protein production.
Learn how axalimogene filolisbac, a modified foodborne bacterium, is transforming cervical cancer treatment through innovative immunotherapy approaches.
Discover how Angiotensin II orchestrates cellular regulation by directing the ubiquitin-proteasome pathway to degrade IP3 receptors, with implications for cardiovascular health.